The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Should you forget Eli Lilly and buy this magnificent biotech instead? Let's find out.

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...